FlexAbility Ablation Catheter, Sensor Enabled
ABBOTT MEDICAL · Decision date Oct 16, 2025
What did the FDA approve?
FDA records P110016/S089 as a supplement to PMA P110016, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Oct 16, 2025.
FDA approval order statement
approval of a revised protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P110016/S080.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track No User Fee
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 16, 2025
- FDA change category
- Postapproval Study Protocol
Regulatory record facts
- Identifier
- P110016/S089
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- OAD
- Decision code
- APPR
- Decision date
- Oct 16, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter.
- Applicant
- Abbott Medical
- Product code
- OAD
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P110016/S089 received
Application receipt date recorded by FDA.
P110016/S089 · FDA decision
Normal 180 Day Track No User Fee
P110016/S091 · Related supplement
FlexAbility Ablation Catheter (Flex) and FlexAbility Ablation Catheter, Sensor Enabled (Flex SE)
P110016/S092 · Related supplement
FlexAbility and FlexAbility Sensor Enabled
P110016/S093 · Related supplement
FlexAbility Ablation Catheter (Flex) and FlexAbility Ablation Catheter, Sensor Enabled (Flex SE)
P110016/S094 · Related supplement
FlexAbility Ablation Catheter; FlexAbilityTM Ablation Catheter, Sensor EnabledTM
P110016/S095 · Related supplement
Ampere Generator
Timeline entries are records held by MedtechLedger for P110016. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P110016
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA supplement | Jan 8, 2026 | FDA | |
FlexAbility and FlexAbility Sensor EnabledP110016/S092 | ABBOTT MEDICAL | PMA supplement | Jan 15, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Apr 9, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Jun 5, 2026 | FDA | |
Ampere GeneratorP110016/S095 | ABBOTT MEDICAL | PMA supplement | Aug 7, 2026 | FDA |
Explore the linked device profile
Other records with product code OAD
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Biosense Webster, Inc. | PMA supplement | Sep 15, 2026 | FDA | |
Therapy Dual-8 Ablation CatheterP040042/S060 | Irvine Biomedical,Inc.(Ibi) | PMA supplement | Sep 3, 2026 | FDA |
THERMOCOOL SMARTTOUCH SF CatheterP030031/S142 | Biosense Webster, Inc. | PMA supplement | Sep 2, 2026 | FDA |
Ampere GeneratorP040042/S059 | Irvine Biomedical,Inc.(Ibi) | PMA supplement | Aug 7, 2026 | FDA |
Ampere GeneratorP060019/S059 | Irvine Biomedical, Inc. | PMA supplement | Aug 7, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 2375 Morse Ave., Plymouth, MN, 55442
Sources and methodology
- Original FDA record: P110016/S089
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



